These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17579972)

  • 1. Driving under the influence of drugs--amphetamine concentrations in oral fluid and whole blood samples.
    Engblom C; Gunnar T; Rantanen A; Lillsunde P
    J Anal Toxicol; 2007 Jun; 31(5):276-80. PubMed ID: 17579972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases.
    Peters FT; Samyn N; Kraemer T; Riedel WJ; Maurer HH
    Clin Chem; 2007 Apr; 53(4):702-10. PubMed ID: 17332148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine.
    Gjerde H; Verstraete AG
    Forensic Sci Int; 2011 Oct; 212(1-3):e26-30. PubMed ID: 21775080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
    Samyn N; De Boeck G; Verstraete AG
    J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of the initial medical examination on matters relating to persons suspected of driving under the influence of amphetamine and its analogs or delta9-tetrahydrocannabinol based on the materials the Department of Forensic Medicine, Pomeranian Medical University in Szczecin].
    Wolski S; Lewandowska E; Kurzejamska-Parafiniuk M
    Ann Acad Med Stetin; 2013; 59(2):147-56. PubMed ID: 25026768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
    Röhrich J; Zörntlein S; Becker J; Urban R
    J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples.
    Kankaanpää A; Gunnar T; Ariniemi K; Lillsunde P; Mykkänen S; Seppälä T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):57-68. PubMed ID: 15358308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving under the influence of amphetamine-like drugs.
    Musshoff F; Madea B
    J Forensic Sci; 2012 Mar; 57(2):413-9. PubMed ID: 22335607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid.
    Cooper G; Wilson L; Reid C; Hand C; Spiehler V
    Forensic Sci Int; 2006 Jun; 159(2-3):104-12. PubMed ID: 16115742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drivers under the influence of drugs of abuse: quantification of cocaine and impaired driving.
    Arroyo A; Sánchez M; Barberia E; Barbal M; Marrón MT; Mora A
    Med Leg J; 2013; 81(Pt 3):135-43. PubMed ID: 24057314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
    Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS
    J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supported liquid extraction (SLE) for the analysis of methylamphetamine, methylenedioxymethylamphetamine and delta-9-tetrahydrocannabinol in oral fluid and blood of drivers.
    Rositano J; Harpas P; Kostakis C; Scott T
    Forensic Sci Int; 2016 Aug; 265():125-30. PubMed ID: 26878366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS.
    Wood M; De Boeck G; Samyn N; Morris M; Cooper DP; Maes RA; De Bruijn EA
    J Anal Toxicol; 2003 Mar; 27(2):78-87. PubMed ID: 12670001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
    Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
    Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.